Your browser doesn't support javascript.
loading
Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells.
Kim, S H; Kang, J G; Kim, C S; Ihm, S-H; Choi, M G; Yoo, H J; Lee, S J.
Affiliation
  • Kim SH; Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
  • Kang JG; Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
  • Kim CS; Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
  • Ihm SH; Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
  • Choi MG; Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
  • Yoo HJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
  • Lee SJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Hallym University, Chuncheon, Republic of Korea. leesj@hallym.ac.kr.
J Endocrinol Invest ; 41(6): 677-689, 2018 Jun.
Article in En | MEDLINE | ID: mdl-29147952
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidones / Pyrimidines / Sulfonamides / Thyroid Neoplasms / Biomarkers, Tumor / Drug Synergism / Dipeptidyl-Peptidase IV Inhibitors / Histone Deacetylase Inhibitors / Hydroxamic Acids Limits: Humans Language: En Journal: J Endocrinol Invest Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidones / Pyrimidines / Sulfonamides / Thyroid Neoplasms / Biomarkers, Tumor / Drug Synergism / Dipeptidyl-Peptidase IV Inhibitors / Histone Deacetylase Inhibitors / Hydroxamic Acids Limits: Humans Language: En Journal: J Endocrinol Invest Year: 2018 Type: Article